医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2022年第64届美国放射肿瘤学会年会(ASTRO)
     
 
 

◆ 会议时间:2022年10月23日至26日
◆ 会议地点:美国 圣安东尼奥(San Antonio)


◆ 会议简介:

2022年第64届美国放射肿瘤学会(ASTRO)年会将于2022年10月23日至26日在美国圣安东尼奥举行。ASTRO年会(美国放疗年会)是世界放射肿瘤学界最重要的年度会议,每年都会吸引超过10,000名来自世界各地的相关专业人士前来参会。

美国放射肿瘤学会(ASTRO)成立于1958年,是世界上首屈一指的放射肿瘤学组织。ASTRO现拥有超过10000名会员,包括医生、护士、生物学家、物理学家、放疗技师、剂量师和其他专业从事放谢治疗的医疗保健专业人员。 作为领先的放射肿瘤学组织,ASTRO致力于通过专业的教育和培训,支持临床实践和卫生政策标准,促进科学研究和宣传宣等手段改善对患者的护理。——未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)。

ASTRO 2022 - American Society for Radiation Oncology (ASTRO) 64th Annual Meeting
Date: October 23 - 26, 2022
Venue: Henry B. Gonzalez Convention Center | San Antonio , USA

Exhibit Dates: October 23 - 25, 2022

Mark your calendar now for the 64th ASTRO Annual Meeting! This is the premier radiation oncology scientific event in the world with more than 11,000 attendees each year. The 2022 ASTRO Annual Meeting—AI and EI: Caring for Patients in a Wireless World—will include a full program with engaging educational and scientific sessions, live SA-CME courses and networking events. We’ll highlight the potential of AI, Big Data and scientific advances while showcasing the central role of human interaction in caring for and curing our patients! We’re excited to continue popular offerings from recent years – such as expanded Cancer Breakthroughs sessions and Storytelling – along with deeper dives into important topics with our Master Class series. We look forward to another memorable meeting and can’t wait to see you in San Antonio!

 


 

ASTRO 2022 摘要征集 - Abstract submission:

常规摘要提交截止日期
Deadline to Submit: 11:59 p.m. Pacific time, Tuesday, March 1, 2022

点此提交摘要>>>Submit Abstract>>>

LBA摘要提交日期
Late-breaking Abstracts: The late-breaking abstract submission site will open on July 25, 2022, and close August 10, 2022.

摘要提交费:
There is a $60 fee per abstract that is non-refundable.

点此了解更多投稿信息>>>>>

Eligibility

  1. Sponsorship or ASTRO membership is not required to submit an abstract.
  2. Abstracts must be received by 11:59 p.m. Pacific time, Tuesday, March 1, 2022. 
  3. All studies in oncology, radiation oncology and radiation-therapy for non-oncologic conditions are eligible for submission. This includes basic and translational science, technology-related, health services research, epidemiologic, patient-focused clinical studies and all phases of trials.
  4. An abstract may only be submitted once. Abstracts of clinically-related subjects should be combined into a single abstract. Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts.
  5. Submit new research. Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown.
  6. Obligation to Register: Acceptance of the abstract by the committee obligates the author to present the paper and pay the meeting registration fee. If circumstances prevent attendance, you must notify ASTRO and arrange for an alternate presenter, preferably a co-author in the Speaker Center. If you do not register and attend the meeting, your abstract will be removed from the program.
  7. Disclosures: The submitter must complete the disclosures for the presenter and all co-authors. Use this form to gather all co-author information and use it when entering the co-authors into the abstract submission site.

Important Deadlines-重要截止日期

  1. Abstracts must be received by 11:59 p.m. Pacific time, Tuesday, March 1, 2022. Abstracts may be edited up until the deadline. Abstracts will be considered ineligible for review if they are incomplete. Abstracts that are unpaid or have payment issues will not be considered. If you do not receive a confirmation receipt, follow up with ASTRO to confirm your “complete” status.
  2. Revisions: Please proof your abstract carefully for formatting, spelling and data errors. Pay special attention to the author order and presenting author designation. Review your confirmation email, as this is how the abstract will be published. Errors can be corrected if sent to ASTRO by June 30, 2022. After this date, we cannot make any corrections. This rule is strictly enforced. Please note: revisions should not be substantive, and should not alter the results or the conclusions of the abstract. Revisions are meant only to correct errors that were made in the initial submission.
  3. Notifications: The person listed as Presenting Author will be notified via email of the disposition of the abstract by late-May 2022. Abstract acceptance obligates the author to present the paper and pay the meeting registration fee. If circumstances prevent attendance, you must notify ASTRO and arrange for an alternate presenter, preferably a co-author.
  4. Withdrawals: If you choose to withdraw your abstract, please change your decision to “withdraw” in the Speaker Center by June 30, 2022 and notify ASTRO staff via email. After this date, your abstract will be published exactly as it was submitted in the International Journal of Radiation Oncology • Biology • Physics (Red Journal).
  5. Late-breaking Abstracts: The late-breaking abstract submission site will open on July 25, 2022, and close August 10, 2022.
  6. Submission of an abstract conveys permission to be posted online and printed in the International Journal of Radiation Oncology • Biology • Physics (Red Journal) (www.redjournal.org).

Presenting Author Responsibility-展示作者的责任

  1. An individual may submit more than one abstract in which they are indicated as the presenting author. However, they may only present one oral presentation. If more than one abstract is selected for oral presentation, an alternate presenter must be assigned, preferably a co-author (this does not apply to poster presentations).
  2. It is the submitter’s responsibility to ensure up-to-date and accurate disclosures are submitted for each co-author on the abstract. ASTRO manages and reports all disclosures as submitted. Potential conflicts with commercial interest for the presenting author and all co-authors must be disclosed at the time of submission.
  3. The presenting author will receive all notifications and email communications related to the accepted abstract(s). The presenting author is responsible for informing all co-authors of acceptance to ASTRO’s Annual Meeting.
  4. ASTRO has developed a policy to handle any violations to the ASTRO Disclosure policy. Any reported violations will be researched and handled according to policy, which can include removal from presenting at future conferences.
  5. Obligation to Register: Acceptance of an abstract obligates the author to present the paper and pay the meeting registration fee. If circumstances prevent attendance, you must notify ASTRO and arrange for an alternate presenter, preferably a co-author. If the presenting author does not register and attend the meeting, your abstract will be removed from the program.

Presentation at Other Meetings

  1. Abstracts should contain new material that has not been presented or published prior to the ASTRO Annual Meeting, October 23-26, 2022. Previously presented abstracts will not be eligible for ASTRO’s official Press Program or Plenary Session.
  2. If the same abstract is accepted for presentation at another major medical meeting or accepted for publication after March 1, 2022, the presenting author must notify ASTRO. The Scientific Committee will review and decide on a case-by-case basis if the abstract will remain in the program.

Properly Formatted Abstract

  1. Abstracts must be properly formatted and organized into four sections identified by the following bolded headers: Purpose/Objectives, Materials/Methods, Results and Conclusions.
  2. Abstracts should include a scientific hypothesis in the Purpose/Objectives section, and implications for research, policy or practice in the Conclusions section, when applicable.
  3. Presentations must give a balanced view of therapeutic options. Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract. ASTRO reserves the right to replace proprietary names with generic names.
  4. Institution names should not be included in the title or body of the abstract. Alternative language is “at one institution” or “a multi-institution” study, etc. This does not apply to cooperative research group names. 
  5. The abstract title should not include results. 
  6. The abstract cannot contain illustrations, images or graphs. If the abstract is accepted, presenters may include these items in their on-site presentations.
  7. An abstract may contain one small table. The maximum character limit, including the title and body of the abstract, is 2,600 characters. Spaces are not counted.
  8. A maximum of 20 authors’ names may be listed on each abstract. There are no exceptions. Authorship credit should only be given if all three of the following criteria are met. There is not mechanism for listing co-lead authors, or co-PI’s. Each author must have made substantial contributions to:
    • conception and design, or analysis and interpretation of data, and
    • drafting the abstract or revising it critically for important intellectual content, and
    • final approval of the version to be submitted/published.
  1. The late-breaking abstract submission site will open on July 25, 2022, and close August 10, 2022.
  2. A late-breaking abstract is an original research abstract containing important late-breaking research results that were not available prior to the regular abstract submission deadline. The research is limited to highly significant and timely findings and cannot be a revision of an abstract submitted prior to the regular submission deadline. Trials in progress are not eligible to be submitted as late-breaking abstracts.
  3. Late-breaking abstracts must not have been submitted, presented, accepted for presentation or published in any other scientific venue.
  4. A special panel of peer reviewers will review the late-breaking abstracts and the corresponding author will be notified of the abstract status by the end of August 2022.

 

参展联系:
John Barrett
john.barrett@spargoinc.com
+1 703-654-6490


ASTRO 2022年美国放疗年会-ASTRO放射治疗肿瘤年会-ASTRO放射年会-美国放射肿瘤学年会


 

◆ 参会对象:
放射科医师,肿瘤科医师,护士,生物学家,物理学家,放疗技师,放射剂量师,药疗企业代表,以及其他相关卫生保健专业人士等等。

 
 
※相关服务※
会议注册服务:30美金起/人/次(服务费)+ 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1500元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们